CEO Anne Wojcicki, who holds roughly half of voting power, is attempting to take the company private. In September, seven ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

Regarding its workforce reduction, which will total 200 employees, CEO Anne Wojcicki called the layoffs a “difficult but necessary” step to keep the company alive. “We are taking these difficult but ...

This decision, described by CEO Anne Wojcicki as “difficult but necessary,” comes as the genetic testing company undergoes a ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company ...

Sales for the Atlanta-based company improved 6.6 percent to $40.22 billion, topping the $39.31 billion that analysts ...

23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

But in announcing the cuts, 23andMe CEO Anne Wojcicki said her goal is to ensure the "long-term success" of its core consumer ...

Me (ME), the company that popularized at-home DNA tests, announced on Tuesday that its sales took a hit during its most ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...